Pharmaceuticals

Former chairman and CEO of Johnson & Johnson Richard B Sellars dies at 94

26 Jun 2010

Gilead Sciences to buy CGI Pharmaceuticals for up to $120 million

26 Jun 2010

Sanofi-Aventis signs global licensing pact with Metabolex for Type II diabetes drug

25 Jun 2010

Merck enters drug distribution pact with South Africa's Adcock Ingram

24 Jun 2010

Piramal Healthcare to buy BioSyntech's assets for $3.82 billion

22 Jun 2010

Sun Pharma, Orion settle litigation over generic Stalevo and Comtan

22 Jun 2010

Sanofi-Aventis signs $750-million microRNA therapeutics deal with Regulus

22 Jun 2010

Cadila gets nod for Phase I trials of novel oral diabetes drug

21 Jun 2010

Specialty drugmakers, Biovail and Valeant Pharmaceuticals to merge

21 Jun 2010

AstraZeneca settles US drug pricing suit for $103 million

19 Jun 2010

Dabur completes merger of Fem Care Pharma

18 Jun 2010

Sun Pharma's epilepsy drug granted US FDA approval

17 Jun 2010

Bayer Schering to develop anti-cancer stem cell therapeutics with OncoMed Pharmaceuticals

17 Jun 2010

Abbott signs $575 million endometriosis drug deal with Neurocrine

16 Jun 2010

Suven secures Japanese patents for two Alzheimer drugs

16 Jun 2010

Cipla to buy stakes in two biotech firms for Rs300 crore

16 Jun 2010

Drug maker Cipla has ventured into biotechnology by acquiring 40-per cent and 25-per cent stakes in two biotech firms in Goa and Hong Kong respectively

Cipla profit rises over 39 per cent to Rs1,081.49 crore

15 Jun 2010

Teva Pharmaceutical hikes stake in diabetes drug developer Andromeda

14 Jun 2010

US court halts launch of Dr Reddy's anti-allergic drug Allegra D24

14 Jun 2010

Global pharma giants to pool data to accelerate Alzheimer treatment

12 Jun 2010

It is the first effort of its kind to create a voluntary industry data standard that will help accelerate new treatment research on brain diseases

GlaxoSmithKline acquires Argentina’s Laboratorios Phoenix for $253 million

11 Jun 2010

Sanofi Aventis signs antibody research deal with Vivalis SA

09 Jun 2010

Grifols to buy Talecris Bio for $3.4 billion

07 Jun 2010

The acquisition will propel the Barcelona-based Grifols to the second-biggest producer of plasma products in the US, behind Baxter International and ahead of Australia’s CSL Ltd

Hydro power generation at country's largest plant records 25-per cent growth

07 Jun 2010

Grifols of Spain in talks to acquire Talecris Biotherapeutics for $3 billion

07 Jun 2010